"A Study of Zoledronic Acid as Neo-Adjuvant, Perioperative Therapy in Patients with Resectable Pancreatic Ductal Adenocarcinoma"
written by Dominic E. Sanford, Matthew R. Porembka, Roheena Z. Panni, Jonathan B. Mitchem, Brian A. Belt, Stacey M. Plambeck-Suess, Goldie Lin, David G. DeNardo, Ryan C. Fields, William G. Hawkins, Steven M. Strasberg, Craig Lockhart, Andrea Wang-Gillam, Simon Peter Goedegebuure, David C. Linehan,
published by Journal of Cancer Therapy, Vol.4 No.3, 2013
has been cited by the following article(s):
  • Google Scholar
  • CrossRef
[1] The new era of cancer immunotherapy: targeting myeloid-derived suppressor cells to overcome immune evasion
[2] Systemic but not MDSC-specific IRF4 deficiency promotes an immunosuppressed tumor microenvironment in a murine pancreatic cancer model
[3] Hypoxia as a barrier to immunotherapy in pancreatic adenocarcinoma
[4] Myeloid-Derived Suppressor Cells and Pancreatic Cancer: Implications in Novel Therapeutic Approaches
[5] 胰腺癌微环境治疗策略的进展与思考
[6] Blood-based analyses of cancer: Circulating myeloid-derived suppressor cells–is a new era coming?
Critical Reviews in Clinical Laboratory Sciences, 2018
[7] Focused ultrasound for immuno-adjuvant treatment of pancreatic cancer: An emerging clinical paradigm in the era of personalized oncotherapy
International Journal of Digital Earth, 2017
[8] Fabrice UHEL
[9] A clinical and biological perspective of human myeloid-derived suppressor cells in cancer
Cellular and Molecular Life Sciences, 2016
[10] Bisphosphonates as potential adjuvants for patients with cancers of the digestive system
World journal of gastroenterology, 2016
[11] Controversies in Neoplastic Myeloplasia
Myeloid-Derived Suppressor Cells and Cancer, 2016
[12] Human neutrophils: Their role in cancer and relation to myeloid-derived suppressor cells
Seminars in Immunology, 2016
[13] Clinical impact of chemotherapy to improve tumor microenvironment of pancreatic cancer
World journal of gastrointestinal oncology, 2016
[14] Role of immune cells in pancreatic cancer from bench to clinical application: An updated review
Medicine, 2016
[15] T-cell programming in pancreatic adenocarcinoma: a review
Cancer Gene Therapy, 2016
[16] Cellules suppressives d'origine myéloïde au cours du sepsis
Thèse, 2016
[17] Obesity-induced Immune Modulation in Pancreatic Cancer
[18] Is the Balloon Dilation Duration in Endoscopic Papillary Balloon Dilation (EPBD) Related to the Occurrence of Post-EPBD Pancreatitis?
[19] Alternative formats
J Clin Neurol, 2015
[20] MDSCs in cancer: Conceiving new prognostic and therapeutic targets
Biochimica et Biophysica Acta (BBA)-Reviews on Cancer, 2015
[21] Novel Role for Tumor-Induced Expansion of
The Journal of Immunology, 2014
[22] Stromal reengineering to treat pancreas cancer
Carcinogenesis, 2014
[23] Molecular Pathways: Myeloid Complicity in Cancer
Clinical Cancer Research, 2014
[24] Stromal re-engineering to treat pancreas cancer
Carcinogenesis, 2014
[25] Unbiased analysis of pancreatic cancer radiation resistance reveals cholesterol biosynthesis as a novel target for radiosensitisation
British journal of cancer, 2014
[26] Successful Treatment of a Gastric Plasmacytoma Using a Combination of Endoscopic Submucosal Dissection and Oral Thalidomide
Clinical endoscopy, 2014
[27] Signaling pathways involved in MDSC regulation
Biochimica et Biophysica Acta (BBA)-Reviews on Cancer, 2014
[28] Endoscopic Submucosal Dissection for Gastric Neoplasm at an Outpatient Clinic: Efficacy and Safety
Clinical endoscopy, 2014
[29] Selective efficacy of zoledronic acid on metastasis in a patient‐derived orthotopic xenograph (PDOX) nude‐mouse model of human pancreatic cancer
Journal of surgical oncology, 2014
[30] Myeloid‐derived suppressor cell heterogeneity in human cancers
Annals of the New York Academy of Sciences, 2014
[31] Novel Role for Tumor-Induced Expansion of Myeloid-Derived Cells in Cancer Cachexia
The Journal of Immunology, 2014
[32] Optimization of Therapeutics against Lethal Pancreatic Cancer
ProQuest Dissertations Publishing, 2013
[33] Μελέτη της δράσης της συνδυασμένης χρήσης ακτινοβολίας Χ και διφωσφονικών σε ανθρώπινες κυτταρικές σειρές καρκίνου του μαστού και μη μικροκυτταρικού …